GC Biopharma Corp. (KRX: 006280)
South Korea
· Delayed Price · Currency is KRW 166,700
-2,300 (-1.36%)
Dec 20, 2024, 3:30 PM KST
GC Biopharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,902,577 | 1,432,354 | 1,478,007 | 2,488,073 | 4,633,750 | 1,512,246 | Upgrade
|
| Market Cap Growth | 39.37% | -3.09% | -40.60% | -46.31% | 206.42% | -2.57% | Upgrade
|
| Enterprise Value | 2,982,960 | 2,368,951 | 2,204,898 | 3,075,936 | 5,228,112 | 1,935,750 | Upgrade
|
| Last Close Price | 166700.00 | 125500.00 | 127930.94 | 212617.71 | 392408.76 | 127521.79 | Upgrade
|
| PE Ratio | - | - | 22.58 | 20.19 | 57.17 | - | Upgrade
|
| Forward PE | 81.71 | 47.35 | 21.09 | 25.00 | 33.91 | 34.29 | Upgrade
|
| PS Ratio | 1.16 | 0.88 | 0.86 | 1.62 | 3.08 | 1.11 | Upgrade
|
| PB Ratio | 1.48 | 0.93 | 0.94 | 1.66 | 3.65 | 1.28 | Upgrade
|
| P/TBV Ratio | 1.80 | 1.34 | 1.33 | 2.31 | 4.30 | 1.50 | Upgrade
|
| P/FCF Ratio | - | - | 24.17 | 105.17 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 12.40 | 19.75 | 128.81 | 37.53 | Upgrade
|
| PEG Ratio | 1.35 | 1.35 | 1.35 | 1.20 | 0.45 | 57.15 | Upgrade
|
| EV/Sales Ratio | 1.81 | 1.46 | 1.29 | 2.00 | 3.48 | 1.43 | Upgrade
|
| EV/EBITDA Ratio | 26.07 | 21.57 | 15.12 | 23.73 | 52.82 | 21.91 | Upgrade
|
| EV/EBIT Ratio | 86.40 | 69.86 | 27.32 | 41.72 | 104.18 | 46.43 | Upgrade
|
| EV/FCF Ratio | -52.22 | - | 36.05 | 130.02 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.59 | 0.47 | 0.37 | 0.40 | 0.45 | 0.41 | Upgrade
|
| Debt / EBITDA Ratio | 7.89 | 6.59 | 3.95 | 4.68 | 5.72 | 5.47 | Upgrade
|
| Debt / FCF Ratio | - | - | 9.41 | 25.64 | - | - | Upgrade
|
| Asset Turnover | 0.60 | 0.63 | 0.69 | 0.67 | 0.73 | 0.74 | Upgrade
|
| Inventory Turnover | 1.99 | 2.39 | 2.52 | 2.28 | 2.52 | 2.49 | Upgrade
|
| Quick Ratio | 0.66 | 0.58 | 0.96 | 1.13 | 1.15 | 1.36 | Upgrade
|
| Current Ratio | 1.55 | 1.20 | 1.81 | 1.97 | 1.92 | 2.40 | Upgrade
|
| Return on Equity (ROE) | -1.47% | -1.28% | 4.53% | 9.89% | 7.26% | -0.55% | Upgrade
|
| Return on Assets (ROA) | 0.76% | 0.82% | 2.02% | 2.00% | 1.53% | 1.42% | Upgrade
|
| Return on Capital (ROIC) | 0.88% | 0.96% | 2.37% | 2.34% | 1.79% | 1.67% | Upgrade
|
| Earnings Yield | -0.99% | -1.86% | 4.43% | 4.95% | 1.75% | -0.24% | Upgrade
|
| FCF Yield | -3.00% | -5.90% | 4.14% | 0.95% | -1.01% | -5.76% | Upgrade
|
| Dividend Yield | 0.90% | 1.20% | - | - | - | - | Upgrade
|
| Payout Ratio | 0.00% | - | 36.64% | 15.02% | 15.69% | - | Upgrade
|
| Buyback Yield / Dilution | - | -125.85% | 55.72% | - | - | Upgrade
| |
| Total Shareholder Return | 0.90% | 1.20% | -125.85% | 55.72% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.